Loading...
XJPX
4578
Market cap35bUSD
Jul 10, Last price  
11,185.00JPY
1D
1.04%
1Q
5.02%
Jan 2017
119.62%
IPO
459.53%
Name

Otsuka Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:4578 chart
P/E
16.20
P/S
2.38
EPS
690.25
Div Yield, %
1.26%
Shrs. gr., 5y
-0.45%
Rev. gr., 5y
11.65%
Revenues
2.47t
+5.97%
955,947,000,0001,084,291,000,0001,090,212,000,0001,154,573,000,0001,218,055,000,0001,452,759,000,0001,599,424,000,0001,445,227,000,0001,195,547,000,0001,239,952,000,0001,291,981,000,0001,396,240,000,0001,422,826,000,0001,498,276,000,0001,737,998,000,0002,018,568,000,0002,329,861,000,0002,468,892,000,000
Net income
363.15b
+5.84%
47,083,000,00067,443,000,00081,001,000,00092,157,000,000122,429,000,000150,989,000,000151,301,000,00084,086,000,00092,563,000,000112,492,000,00082,492,000,000127,151,000,000148,137,000,000125,463,000,000133,906,000,000121,616,000,000343,120,000,000363,151,000,000
CFO
403.58b
+13.80%
58,470,000,000173,508,000,00087,746,000,000147,618,000,000119,340,000,000226,461,000,00088,535,000,000257,892,000,000142,004,000,000102,832,000,000135,821,000,000192,634,000,000232,839,000,000228,864,000,000211,848,000,000283,232,000,000354,638,000,000403,579,000,000
Dividend
Dec 29, 202670 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
IPO date
Dec 15, 2010
Employees
33,482
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT